Call-for-Papers
2018-09-11
Whioce Publishing Pte Ltd and the Editor-in-chief invite all authors to submit their manuscripts to our newly launched journal, Gene Science and Engineering, for peer review.
Read more about Call-for-PapersAnnouncements
-
-
Artificial cells are tiny bacteria fighters
2018-09-11"Lego block" artificial cells that can kill bacteria have been created by researchers at the University of California, Davis Department of Biomedical Engineering. The work is reported Aug. 29 in the journal ACS Applied Materials and Interfaces.
"We engineered artificial cells from the bottom-up -- like Lego blocks -- to destroy bacteria," said Assistant Professor Cheemeng Tan, who led the work. The cells are built from liposomes, or bubbles with a cell-like lipid membrane, and purified cellular components including proteins, DNA and metabolites.
Read more about Artificial cells are tiny bacteria fighters -
The first gene-silencing drug wins FDA approval
2017-06-08A Nobel Prize–winning discovery — that small double-stranded RNA molecules can silence genes by interrupting the translation of DNA’s instructions into proteins — is finally delivering on its medical promise.
The first drug that takes advantage of this natural biological process, called RNA interference, was approved August 10 by the U.S. Food and Drug Administration. It targets a rare hereditary disease that causes misshapen proteins to build up in patients’ nerves, tissues and organs, causing loss of sensation, organ failure and even death.
Hereditary transthyretin amyloidosis, or ATTR, affects about 50,000 people worldwide. This drug will help the subset of those patients who have neurological impairments.
Read more about The first gene-silencing drug wins FDA approval
